Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis

IntroductionRemdesivir (RDV) and nirmatrelvir/ritonavir (NRM/RTV) are two antiviral agents for treating outpatient adults with mild to moderate symptomatic COVID-19 at high risk of developing a severe disease. The review objectives are to compare the efficacy and safety of these antivirals based on...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Giacomo Berti, Daniele Mengato, Honoria Ocagli, Gianmarco Chinellato, Maria Mazzitelli, Anna Maria Cattelan, Ileana Baldi, Francesca Venturini
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2025-04-01
Serie:	Frontiers in Pharmacology
Soggetti:	COVID-19 remdesivir nirmatrelvir-ritonavir network meta-analysis outpatient cost-analysis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1537018/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!